NEWS

19 Dec 2019 - Performance Report: Spectrum Strategic Income Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | |
Manager Comments | The portfolio remains well diversified with a broad spread of securities by legal structure. Bank T2 capital remains a healthy 25% of the portfolio, whilst senior unsecured and senior secured represent 28% and 11% respectively. The fund holds 14% in ASX listed securities. Spectrum emphasise that, with 10% of the portfolio in cash, the Fund can take advantage of any credit spread weakness. The portfolio continues to maintain an investment-grade rating with an average credit rating of BBB+. Spectrum believe Trump's twitter announcements throughout November were the catalyst for a strong equity market earlier in the month. Their view is that increasing tensions between the US and China will keep the market on its toes. They noted global debt continues to rise and believe this may represent a problem over time, especially so if inflation or interest rates rise in the US and/or globally. They also believe markets in Australia will continue to take their lead from the US markets. |
More Information |

19 Dec 2019 - A blood test for cancer

19 Dec 2019 - Performance Report: Bennelong Emerging Companies Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | The Fund may invest in securities expected to be listed on the ASX within 12 months. The Fund may also invest in securities listed, or expected to be listed, on other exchanged where such securities relate to ASX-listed securities |
Manager Comments | The Fund's Sharpe and Sortino ratios for performance since inception, 1.53 and 2.69 respectively, by contrast with the Index's Sharpe of 1.16 and Sortino of 1.78, highlight the Fund's capacity to achieve superior risk-adjusted returns whilst also avoiding the market's downside volatility. The Fund's top holdings at the end of the month included Viva Leisure, Bwx and Mader. Bennelong noted that, whilst performance has been reasonably strong, they continue to find very attractive opportunities among emerging companies that they believe should position the Fund for decent future returns over time. |
More Information |

19 Dec 2019 - Performance Report: 4D Global Infrastructure Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | The fund will be managed as a single portfolio of listed global infrastructure securities including regulated utilities in gas, electricity and water, transport infrastructure such as airports, ports, road and rail as well as communication assets such as the towers and satellite sectors. The portfolio is intended to have exposure to both developed and emerging market opportunities, with country risk assessed internally before any investment is considered. The maximum absolute position of an individual stock is 7% of the fund. |
Manager Comments | The strongest portfolio performer for the month was Canadian renewable player Boralex (+14.8%) with the market reacting well to the Q3 results and positive momentum in their project pipeline. The weakest performer was Indonesian toll road operator Jasa Marga (-9.4%). In 4D's view, this weakness was a buying opportunity with all November news supporting the Jasa Marga investment thesis. As at the end of November, the Fund had an exposure of 35% to Developed Europe, 32% to Emerging Markets, 27% to North America and held 6% in cash. 4D noted that, despite a slowing global macro environment, it remains supportive of their overweight positioning to user pay assets. However, ongoing geo-political issues see them limiting exposure to certain regions (e.g. UK). |
More Information |

19 Dec 2019 - Performance Report: DS Capital Growth Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | The investment team looks for industrial businesses that are simple to understand; they generally avoid large caps, pure mining, biotech and start-ups. They also look for: - Access to management; - Businesses with a competitive edge; - Profitable companies with good margins, organic growth prospects, strong market position and a track record of healthy dividend growth; - Sectors with structural advantage and barriers to entry; - 15% p.a. pre-tax compound return on each holding; and - A history of stable and predictable cash flows that DS Capital can understand and value. |
Manager Comments | The Fund's Sharpe and Sortino ratios, 1.82 and 3.78 respectively, by contrast with the Index's Sharpe of 0.83 and Sortino of 1.24, highlight the Fund's capacity to achieve superior risk-adjusted returns whilst avoiding the market's downside volatility over the long-term. The Fund's up-capture ratio of 59.7% and down-capture ratio of 19.4% indicate that, on average, the Fund has capture significantly more of the market's upside than its downside since the Fund began. The Fund aims to deliver an average return of at least 10% p.a. through the economic cycle, with a focus on capital preservation. The Fund comprises a concentrated portfolio of small and mid-cap investments selected through a process of quantitative and qualitative analysis. |
More Information |

19 Dec 2019 - Performance Report: Cyan C3G Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | Cyan C3G Fund is based on the investment philosophy which can be defined as a comprehensive, clear and considered process focused on delivering growth. These are identified through stringent filter criteria and a rigorous research process. The Manager uses a proprietary stock filter in order to eliminate a large proportion of investments due to both internal characteristics (such as gearing levels or cash flow) and external characteristics (such as exposure to commodity prices or customer concentration). Typically, the Fund looks for businesses that are one or more of: a) under researched, b) fundamentally undervalued, c) have a catalyst for re-rating. The Manager seeks to achieve this investment outcome by actively managing a portfolio of Australian listed securities. When the opportunity to invest in suitable securities cannot be found, the manager may reduce the level of equities exposure and accumulate a defensive cash position. Whilst it is the company's intention, there is no guarantee that any distributions or returns will be declared, or that if declared, the amount of any returns will remain constant or increase over time. The Fund does not invest in derivatives and does not use debt to leverage the Fund's performance. However, companies in which the Fund invests may be leveraged. |
Manager Comments | The Fund returned -3.2% in November. Cyan noted many of the companies in which they had enjoyed strong gains in prior months have endured selling pressure. They added that, while Cyan typically look at an investment timeframe in excess of 2 years, the stock market does value and price companies on a daily basis which can sometimes result in large fluctuations in short-term prices. Despite the underwhelming monthly return, Cyan remain optimistic about the Fund's outlook. They noted that, in addition to the positive expectations for their core holdings, there has been a deluge of corporate activity and new issues, some of which have the potential to be attractive longer-term investments. |
More Information |

19 Dec 2019 - China Journal, musings from a small cap investor

18 Dec 2019 - Performance Report: Harvest Lane Asset Management Absolute Return Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | Harvest Lane Asset Management employs a conservative, highly selective and opportunistic approach. Using their extensive knowledge in the area of corporate actions, the Fund's managers assess each opportunity based on a thoughtful, diligent and disciplined process and invest where they believe an opportunity exists to generate above average investment returns relative to the risk incurred. Investment decisions are made without speculating on market direction, with rigid risk controls enforced to minimise the risk of large losses of investor capital. The Fund invests in securities that are predominantly listed on the ASX and occasionally in those listed in other developed markets. Equity swaps and other derivatives may be used at times to reduce risk. The fund typically holds high levels of cash in the absence of sufficiently attractive opportunities to deploy investor capital in accordance with its objectives. |
Manager Comments | Harvest Lane noted activity was predominantly driven by news flow in existing positions, although they continue to see a steady stream of deal flow. A handful of late stage deals completed, bringing a healthy amount of bonus franking credits with them which contributed to the effective return to investors and came in addition to the headline published returns. Harvest Lane's view is that 2019 was a somewhat frustrating year for prudently managed active investment approaches that don't gamble on broader market conditions. They expect 2020 to provide some very different market conditions to sort the wheat from the chaff. |
More Information |

18 Dec 2019 - Performance Report: Wheelhouse Global Equity Income Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | To pursue this objective, the Investment Manager is responsible for actively managing, monitoring and tailoring the integration of derivative contracts alongside the Morningstar Portfolio, while taking into account changing market and stock specific conditions. The Investment Manager is responsible for maximising the structural benefits of short option positions (lowered Volatility, improved capital preservation, higher income generation), whilst mitigating, minimising and monitoring the structural negatives (variable market exposure, option expiries, collateral management and asymmetric return profiles). In addition, long derivatives positions are also used to enhance the capital preservation characteristics of the Fund in more extreme market movements. As a consequence of the integration of Derivatives, returns of the strategy, intra-cycle, are expected to vary from the underlying Morningstar Portfolio due to these characteristics. For example in weak markets, or in extended sideways markets, the Fund is expected to outperform relative to the Morningstar Portfolio. Conversely in strong positive markets the Fund is expected to underperform. |
Manager Comments | The Fund's November return comprised +1.57% from the portfolio (in USD) and +1.82% from the weakening AUD against the USD. Top contributors included ServiceNow, Amgen, Adobe, Guidewire Software and Western Union. Detractors included Elekta AB, Kao Corp, Richemont, KLA-Corp and Cheniere Energy. The strategy's high-income generation and active tail risk program are designed to lower risk and deliver equity returns with a smoother, more retiree-friendly return profile. As a result, Wheelhouse expect returns to add relative value in weak and low-growth markets and to drag in more positive markets. |
More Information |

18 Dec 2019 - Performance Report: Frazis Fund
Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | The manager follows a disciplined, process-driven, and thematic strategy focused on five core investment strategies: 1) Growth stocks that are really value stocks; 2) Traditional deep value; 3) The life sciences; 4) Miners and drillers expanding production into supply deficits; 5) Global special situations; The manager uses a macro overlay to manage exposure, hedging in three ways: 1) Direct shorts 2) Upside exposure to the VIX index 3) Index optionality |
Manager Comments | The Frazis Fund rose +7.5% in November, outperforming AFM's Global Equity Index by +3.1%. This follows from the Fund's October return of +7.6% and takes CYTD performance to +29.35% versus the Index's +27.55%. The Fund benefited from strong contributions from Carvana and Amarin during November. Amarin is a US biotech company marketing pure EPA, a component of fish oil. Frazis noted research results released in Japan and also by Amarin both showed EPA to be capable of reducing the risk of heart attack on a similar order of magnitude as statins. Frazis remain excited about this opportunity. This month Frazis have also released an Insights article, 'A blood test for cancer', in which they discuss their views on Guardant Health, a new company in the portfolio developing a blood test for cancer. Frazis Capital Partners are pleased with how the fundamentals underlying the Fund's long-term investments are progressing. These are in companies they've discussed in previous months' performance reports, including Afterpay, Carvana, Pinduoduo, Amarin, Pointsbet, diagnostics and US software. They noted that, after a long period of investment over the past year, they are hoping to reap the rewards of these investments over the next few years and are also optimistic the Fund's good fortune in the life sciences will continue. |
More Information |